Embolization Market Synopsis:
Embolization Market Size Was Valued at USD 2.24 Billion in 2023, and is Projected to Reach USD 4.67 Billion by 2032, Growing at a CAGR of 8.5% From 2024-2032.
The Transcutaneous Electrical Nerve Stimulation (TENS) industry is related to the manufacture and selling of TENS devices for controlling chronic pain using low voltage electricity. These devices are preferred for the control of various types of chronic and acute pain conditions such us arthritis, labor pains, and post-surgical pain. TENS therapy is without contacts and drugs, making it ideal for populace and healthcare professionals who shun conventional analgesic modalities.
Although the TENS market has been stagnant over the past couple of years, increasing consumer interest in pain-relief devices that do not rely heavily on drug-based products is a primary reason for this market’s growth. TENS devices are small portable devices that apply electrical impulses through electrodes on the skin to the nerves with the hope of having reduced pain. These are devoid of side effects and complications and as such are preferred for most general chronic and acute painful conditions, childbirth and postoperative pains.
TENS devices can be used at home because they require less professional attention as they are prescribed for the long-term control of chronic pain. Newer models of TENS are easy to operate, lightweight and can be easily customized, thus the are now being embraced for home therapy and in rehabilitation facilities. It also represents a growing awareness of market opportunities for TENS therapy for wide area applications even in sports medicine or physical therapy. In summary, the total of this market is believed to increase as it becomes apparent that pain sufferers are interested in non-pharmacological methods, and as advancements enhance TENS products and future capabilities.
Embolization Market Trend Analysis:
Growing Adoption of Portable TENS Devices
- Transportable TENS devices idealized for home use because of their flexibility, operability and convenience by patients. It is different from the stationary models which are commonly portable TENS units commonly utilised in the clinical setting. This has mainly been contributed by increasing incidences of chronic pain cases such as arthritis that would necessitate routine use of pain management that is readily available. When it comes to the patient convenience portable TENS units are a perfect choice that could fit practically any scenario and provide immediate relief.
- Another positive attribute of a ‘portability’ factor which augments the development scope of virtual nursing services in the foreseeable future is the growing need for remote medical care and the concept of ‘self-care’. Innovation in the realm of battery longevity, digital read outs, and portability are creating TENS devices that are small enough to be palm-held or fit in a pocket or purse, making them perfect for the individuals on the go. The change to portability is beneficial for market development as it expands the client base and stimulates them to make more frequent use of TENS therapy outside clinical settings.
Expanding Applications in Sports Medicine and Physical Therapy
- TENS devices are growing in use in the sectors of sports medicine and physical therapy which serves as a big market growth area. Sport and physically engaged personnel choose the TENS therapy to cope with pain that arises from a particular injury as well as to decrease general muscle soreness and facilitate quicker muscle recovery. The forwarded technology is considered an enhancement to rehabilitation programmes and its applicability can enable the athlete to rehabilitate without taking substances that may pose negative impacts on his or her performance.
- In physical therapy TENS devices are being used to supplement the recovery and management of musculoskeletal pain as more people look for non-pharmacological ways to manage pain arising from a muscle pull, or during the post-surgery rehabilitation process. As knowledge concerning the possibilities of using TENS in physiotherapy for treating various injuries increases between physiotherapists and trainers, more clinics and rehabilitation centers will buy such devices. Since the use of Specnex in sports associated with physical therapy is a new branch which has not bee explored yet then there is vast market that can be explored.
Embolization Market Segment Analysis:
Embolization Market Segmented on the basis of product type, procedure, application, end user, and region
By Product Type, Embolic Agents segment is expected to dominate the market during the forecast period
- The TENS market is divided into two types of devices: portable TENS units and desktop TENS units. Conventional TENS devices are transportable and have become used due to their mobility and they are mostly used at home to allow the patients to self-administer the treatment. They are normally smaller, with batteries, and provide easier pain control measures which makes them suitable for people with chronic pain who will often be in need of TENS treatment.
- Desktop TENS devices on the other hand are more advanced in power, and are usually used in clinical as well as therapeutic practices. They are often bigger, often need to be installed by a specialist, and contain more settings for small fine-tuning. , yet the portable type is growing at a faster rate because of the increasing trend toward home-based healthcare equipment in health care institutions.
By Application, Transcatheter Arterial Embolization (TAE) segment expected to held the largest share
- TENS devices are widely useful in several areas, though their most common use is for chronic pain. Mind you, conditions that are chronic like arthritis, fibromyalgia, and back pain have boosted the use of TENS therapy. Such patients need chronic, non-pharmacological pain control, for which TENS devices are effective in the management. This segment has been growing as more people look for non-surgical means of treating their chronic pain.
- Other uses are; Somatic pain, labour and post operative pain. TENS therapy is short term used for acute pain conditions while for labor pain as a non-pharmacological pain control measure during childbirth. In the post-surgical scenario, TENS therapy has also been used on increased Note that people have shifted to TENS therapy in search of an effective pain management method that would help them minimize their medication intake during the recovery period. These cases show that TENS therapy can be applied in the treatment of different forms of pain.
Embolization Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America has the largest market share of TENS due to increased expenditure in healthcare, existence of modern health care facilities and emphasis on non-pharmacological treatment strategies. The region is characterized by a high burden of chronic pain, which creates the need to develop conservative, evidence-based pain intervention solutions. In conjunction with a high incidence of diseases, such as arthritis and back pain, the North American region continues to be the largest market for TENS therapy.
- Also, the legal structure in North America continues to push for non-opioid pain management solutions which positively fuels the growth of TENS market. Interest in TENS devices has been fueled by an understanding of the risks linked with quantity usage of opioids for varied conditions. It is in this respect that the accent on the various approaches might help maintain North America’s dominance in the market.
Active Key Players in the Embolization Market:
- DJO Global (United States)
- Zynex Medical (United States)
- Omron Healthcare (Japan)
- NeuroMetrix, Inc. (United States)
- Pure Enrichment (United States)
- iReliev (United States)
- TENS Units (United States)
- Beurer GmbH (Germany)
- HealthmateForever (United States)
- Roscoe Medical (United States)
- BioMedical Life Systems (United States)
- RS Medical (United States)
- Other Active Players
Key Industry Developments in the Embolization Market:
- In February 2024 Al, a leading French expert in medical imaging Al, unveiled a strategic alliance to incorporate its CE-marked CINA-IPE solution into the Blackford Al Platform. This partnership provides healthcare providers with advanced tools to identify incidental pulmonary embolisms more effectively during routine CT scans.
|
Embolization Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.24 Billion |
|
Forecast Period 2024-32 CAGR: |
8.5% |
Market Size in 2032: |
USD 4.67 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Embolization Market by By Product Type (2018-2032)
4.1 Embolization Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Embolic Agents
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Embolization Coils
4.5 Detachable Coils
4.6 Pushable Coils
4.7 Liquid Embolics
4.8 Microspheres
4.9 Other
Chapter 5: Embolization Market by By Procedure (2018-2032)
5.1 Embolization Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Transcatheter Arterial Embolization (TAE)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Transcatheter Arterial Chemoembolization (TACE)
5.5 Transcatheter Arterial Radioembolization (TARE)
Chapter 6: Embolization Market by By Application (2018-2032)
6.1 Embolization Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Oncology
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Neurology
6.5 Peripheral Vascular Disease
6.6 Urology
6.7 Other
Chapter 7: Embolization Market by By End User (2018-2032)
7.1 Embolization Market Snapshot and Growth Engine
7.2 Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
7.3.3 Key Market Trends, Growth Factors, and Opportunities
7.3.4 Geographic Segmentation Analysis
7.4 Ambulatory Surgical Centers
7.5 Clinics
7.6 Other
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Embolization Market Share by Manufacturer (2024)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 DJO GLOBAL (UNITED STATES)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ZYNEX MEDICAL (UNITED STATES)
8.4 OMRON HEALTHCARE (JAPAN)
8.5 NEUROMETRIX INC. (UNITED STATES)
8.6 PURE ENRICHMENT (UNITED STATES)
8.7 IRELIEV (UNITED STATES)
8.8 TENS UNITS (UNITED STATES)
8.9 BEURER GMBH (GERMANY)
8.10 HEALTHMATEFOREVER (UNITED STATES)
8.11 ROSCOE MEDICAL (UNITED STATES)
8.12 BIOMEDICAL LIFE SYSTEMS (UNITED STATES)
8.13 RS MEDICAL (UNITED STATES)
8.14 OTHER ACTIVE PLAYERS
Chapter 9: Global Embolization Market By Region
9.1 Overview
9.2. North America Embolization Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By By Product Type
9.2.4.1 Embolic Agents
9.2.4.2 Embolization Coils
9.2.4.3 Detachable Coils
9.2.4.4 Pushable Coils
9.2.4.5 Liquid Embolics
9.2.4.6 Microspheres
9.2.4.7 Other
9.2.5 Historic and Forecasted Market Size By By Procedure
9.2.5.1 Transcatheter Arterial Embolization (TAE)
9.2.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.2.5.3 Transcatheter Arterial Radioembolization (TARE)
9.2.6 Historic and Forecasted Market Size By By Application
9.2.6.1 Oncology
9.2.6.2 Neurology
9.2.6.3 Peripheral Vascular Disease
9.2.6.4 Urology
9.2.6.5 Other
9.2.7 Historic and Forecasted Market Size By By End User
9.2.7.1 Hospitals
9.2.7.2 Ambulatory Surgical Centers
9.2.7.3 Clinics
9.2.7.4 Other
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Embolization Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By By Product Type
9.3.4.1 Embolic Agents
9.3.4.2 Embolization Coils
9.3.4.3 Detachable Coils
9.3.4.4 Pushable Coils
9.3.4.5 Liquid Embolics
9.3.4.6 Microspheres
9.3.4.7 Other
9.3.5 Historic and Forecasted Market Size By By Procedure
9.3.5.1 Transcatheter Arterial Embolization (TAE)
9.3.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.3.5.3 Transcatheter Arterial Radioembolization (TARE)
9.3.6 Historic and Forecasted Market Size By By Application
9.3.6.1 Oncology
9.3.6.2 Neurology
9.3.6.3 Peripheral Vascular Disease
9.3.6.4 Urology
9.3.6.5 Other
9.3.7 Historic and Forecasted Market Size By By End User
9.3.7.1 Hospitals
9.3.7.2 Ambulatory Surgical Centers
9.3.7.3 Clinics
9.3.7.4 Other
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Embolization Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By By Product Type
9.4.4.1 Embolic Agents
9.4.4.2 Embolization Coils
9.4.4.3 Detachable Coils
9.4.4.4 Pushable Coils
9.4.4.5 Liquid Embolics
9.4.4.6 Microspheres
9.4.4.7 Other
9.4.5 Historic and Forecasted Market Size By By Procedure
9.4.5.1 Transcatheter Arterial Embolization (TAE)
9.4.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.4.5.3 Transcatheter Arterial Radioembolization (TARE)
9.4.6 Historic and Forecasted Market Size By By Application
9.4.6.1 Oncology
9.4.6.2 Neurology
9.4.6.3 Peripheral Vascular Disease
9.4.6.4 Urology
9.4.6.5 Other
9.4.7 Historic and Forecasted Market Size By By End User
9.4.7.1 Hospitals
9.4.7.2 Ambulatory Surgical Centers
9.4.7.3 Clinics
9.4.7.4 Other
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Embolization Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By By Product Type
9.5.4.1 Embolic Agents
9.5.4.2 Embolization Coils
9.5.4.3 Detachable Coils
9.5.4.4 Pushable Coils
9.5.4.5 Liquid Embolics
9.5.4.6 Microspheres
9.5.4.7 Other
9.5.5 Historic and Forecasted Market Size By By Procedure
9.5.5.1 Transcatheter Arterial Embolization (TAE)
9.5.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.5.5.3 Transcatheter Arterial Radioembolization (TARE)
9.5.6 Historic and Forecasted Market Size By By Application
9.5.6.1 Oncology
9.5.6.2 Neurology
9.5.6.3 Peripheral Vascular Disease
9.5.6.4 Urology
9.5.6.5 Other
9.5.7 Historic and Forecasted Market Size By By End User
9.5.7.1 Hospitals
9.5.7.2 Ambulatory Surgical Centers
9.5.7.3 Clinics
9.5.7.4 Other
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Embolization Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By By Product Type
9.6.4.1 Embolic Agents
9.6.4.2 Embolization Coils
9.6.4.3 Detachable Coils
9.6.4.4 Pushable Coils
9.6.4.5 Liquid Embolics
9.6.4.6 Microspheres
9.6.4.7 Other
9.6.5 Historic and Forecasted Market Size By By Procedure
9.6.5.1 Transcatheter Arterial Embolization (TAE)
9.6.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.6.5.3 Transcatheter Arterial Radioembolization (TARE)
9.6.6 Historic and Forecasted Market Size By By Application
9.6.6.1 Oncology
9.6.6.2 Neurology
9.6.6.3 Peripheral Vascular Disease
9.6.6.4 Urology
9.6.6.5 Other
9.6.7 Historic and Forecasted Market Size By By End User
9.6.7.1 Hospitals
9.6.7.2 Ambulatory Surgical Centers
9.6.7.3 Clinics
9.6.7.4 Other
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Embolization Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By By Product Type
9.7.4.1 Embolic Agents
9.7.4.2 Embolization Coils
9.7.4.3 Detachable Coils
9.7.4.4 Pushable Coils
9.7.4.5 Liquid Embolics
9.7.4.6 Microspheres
9.7.4.7 Other
9.7.5 Historic and Forecasted Market Size By By Procedure
9.7.5.1 Transcatheter Arterial Embolization (TAE)
9.7.5.2 Transcatheter Arterial Chemoembolization (TACE)
9.7.5.3 Transcatheter Arterial Radioembolization (TARE)
9.7.6 Historic and Forecasted Market Size By By Application
9.7.6.1 Oncology
9.7.6.2 Neurology
9.7.6.3 Peripheral Vascular Disease
9.7.6.4 Urology
9.7.6.5 Other
9.7.7 Historic and Forecasted Market Size By By End User
9.7.7.1 Hospitals
9.7.7.2 Ambulatory Surgical Centers
9.7.7.3 Clinics
9.7.7.4 Other
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Embolization Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.24 Billion |
|
Forecast Period 2024-32 CAGR: |
8.5% |
Market Size in 2032: |
USD 4.67 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
The forecast period in the Embolization Market research report is 2024-2032.
DJO Global (United States), Zynex Medical (United States), Omron Healthcare (Japan), NeuroMetrix, Inc. (United States), Pure Enrichment (United States), iReliev (United States), TENS Units (United States), Beurer GmbH (Germany), HealthmateForever (United States), Roscoe Medical (United States), BioMedical Life Systems (United States), RS Medical (United States), Other Active Players.
The Embolization Market is segmented into Product Type, Procedure, Application, End User and region. By Product Type, the market is categorized into Embolic Agents, Embolization Coils, Detachable Coils, Pushable Coils, Liquid Embolics, Microspheres, Others. By Procedure, the market is categorized into Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), By Application, the market is categorized into Oncology, Neurology, Peripheral Vascular Disease, Urology, Other. By End User, the market is categorized into Hospitals, Ambulatory Surgical Centers, Clinics, Other. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
The Transcutaneous Electrical Nerve Stimulation (TENS) industry is related to the manufacture and selling of TENS devices for controlling chronic pain using low voltage electricity. These devices are preferred for the control of various types of chronic and acute pain conditions such us arthritis, labor pains, and post-surgical pain. TENS therapy is without contacts and drugs, making it ideal for populace and healthcare professionals who shun conventional analgesic modalities.
Embolization Market Size Was Valued at USD 2.24 Billion in 2023, and is Projected to Reach USD 4.67 Billion by 2032, Growing at a CAGR of 8.5% From 2024-2032.
